This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bucklin, S E Articles by Morrison, D C Search for Related Content PubMed PubMed Citation Articles by Bucklin, S E Articles by Morrison, D C

An interleukin-6-induced acute-phase response does not confer protection against lipopolysaccharide lethality.

Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City 66160.

ABSTRACT

Lipopolysaccharide (LPS), a component of gram-negative bacterial outer cell walls, can stimulate lymphoreticular cells to produce cytokines such as tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1), and IL-6. One of these proinflammatory cytokines, IL-6, induces hepatic synthesis of a class of proteins termed acute-phase proteins. D-Galactosamine inhibits acute-phase protein synthesis and concurrently sensitizes mice to a lethal dose of LPS approximately 10,000-fold. From these observations, we hypothesized that the acute-phase response may serve as a defense mechanism for protection of the host against the deleterious effects of LPS. To test this hypothesis, murine recombinant IL-6 (mrIL-6) was used to induce an acute-phase response prior to a lethal LPS challenge in both D-galactosamine-treated and normal mice. Induction of the acute-phase response by mrIL-6 was quantitated by measuring the concentrations of fibrinogen and complement component C3, two well-characterized acute-phase proteins, in the circulation. The effect of acute-phase and normal serum on TNF-alpha release by peritoneal macrophages stimulated with LPS in vitro was also examined. The results of these studies confirmed the induction of the acute-phase response by mrIL-6, as reflected in an approximate doubling in circulating levels of fibrinogen and C3. However, when either D-galactosamine-sensitized or normal mice were challenged with a lethal dose of LPS at various times after mrIL-6 administration, the acute-phase response induced by mrIL-6 did not alter either cumulative lethality or the kinetics of lethality. Additionally, compared with normal serum, acute-phase serum did not affect TNF-alpha release by peritoneal macrophages following LPS-mediated stimulation in vitro. Collectively, these studies would not support a dominant role for an IL-6-mediated acute-phase response as contributing to the resistance of normal mice compared with D-galactosamine-sensitized mice in LPS-induced lethal toxicity.

This article has been cited by other articles:

• Cavaillon, J.-M., Annane, D. (2006). Invited review: Compartmentalization of the inflammatory response in sepsis and SIRS. Innate Immunity 12: 151-170 [Abstract]  
• Silverstein, R. (2004). Review: D-Galactosamine lethality model: scope and limitations. Innate Immunity 10: 147-162 [Abstract]  
• HACKETT, S.J., THOMSON, A.P. J., HART, C.A. (2001). Cytokines, chemokines and other effector molecules involved in meningococcal disease. J Med Microbiol 50: 847-859 [Abstract] [Full Text]  
• MATESIC, L. E., NIEMITZ, E. L., DE MAIO, A., REEVES, R. H. (2000). Quantitative trait loci modulate neutrophil infiltration in the liver during LPS-induced inflammation. FASEB J. 14: 2247-2254 [Abstract] [Full Text]  
• Galdiero, M., Marcatili, A., Cipollaro de l'ero, G., Nuzzo, I., Bentivoglio, C., Galdiero, M., Carratelli, C. R. (1999). Effect of Transforming Growth Factor beta  on Experimental Salmonella typhimurium Infection in Mice. Infect. Immun. 67: 1432-1438 [Abstract] [Full Text]  
• Greisman, S.E., Johnston, C.A. (1997). Review: Evidence against the hypothesis that antibodies to the inner core of lipopolysaccharides in antisera raised by immunization with enterobacterial deep-rough mutants confer broad-spectrum protection during Gram-negative bacterial sepsis. Innate Immunity 4: 123-153 [Abstract]  
• van der Poll, T., Keogh, C.V., Helfgott, D., Berman, L., Buurman, W.A., Lowry, S.F. (1996). Effects of anti-interleukin 6 on inflammatory responses during murine septic peritonitis. Innate Immunity 3: 463-470 [Abstract]  
• Bucklin, S.E., Russell, S.W., Morrison, D.C. (1994). Augmentation of anti-cytokine immunotherapy by combining neutralizing monoclonal antibodies to interferon-{gamma} and the interferon-{gamma} receptor: protection in endotoxin shock. Innate Immunity 1: 45-51 [Abstract]